Companies › LITS

Lite Strategy Inc (LITS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001262104 · EDGAR filings · Updated 2026-07-24

Lite Strategy Inc (LITS) has reported institutional ownership of 17.3%, with 36 institutional managers holding positions valued at $6.83M per the latest 13F reporting period.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-25 — Insider transaction reported (Form 4)
• 2026-05-13 — Current report (8-K) filed
• 2026-05-13 — Quarterly report (10-Q) filed
• 2026-02-17 — SCHEDULE 13G/A filed
• 2026-02-17 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Lite Strategy Inc has 36 institutional holders and institutional ownership of 17.3%.

Insider activity

Insiders reported 4 transactions (2 buys, 1 sells) across 6 reporting insiders, with a net reported value of −$825.4K.

Related companies

Kyntra Bio Inc (KYNB) · CERVOMED INC (CRVO) · TEVOGEN BIO HOLDINGS INC (TVGN) · DarioHealth Corp (DRIO) · Traws Pharma Inc (TRAW) · HARVARD BIOSCIENCE INC (HBIO)